IL HB1780 | 2021-2022 | 102nd General Assembly
Status
Completed Legislative Action
Spectrum: Moderate Partisan Bill (Democrat 22-4)
Status: Passed on June 10 2022 - 100% progression
Action: 2022-06-10 - Public Act . . . . . . . . . 102-1055
Text: Latest bill text (Chaptered) [HTML]
Spectrum: Moderate Partisan Bill (Democrat 22-4)
Status: Passed on June 10 2022 - 100% progression
Action: 2022-06-10 - Public Act . . . . . . . . . 102-1055
Text: Latest bill text (Chaptered) [HTML]
Summary
Creates the Drug Take-Back Act. Requires covered manufacturers to, no later than July 1, 2022 or 6 months after becoming a covered manufacturer, whichever is later, participate in an approved drug take-back program or have established and implemented a drug take-back program independently or as part of a group of covered manufacturers. Provides requirements for the drug take-back program and for manufacturer program operators. Requires each manufacturer program operator to submit a proposal for the establishment and implementation of a drug take-back program to the Environmental Protection Agency for review and approval. Contains provisions regarding changes or modifications to drug take-back programs, promotion of drug take-back programs, annual reports, funding, and reimbursement. Requires covered manufacturers and manufacturer program operators to submit an annual $5,000 registration fee. Specifies civil penalties for violation of the Act. Preempts home rule powers. Contains other provisions. Amends the Freedom of Information Act. Provides that proprietary information submitted to the Environmental Protection Agency under the Drug Take-Back Act is exempt from inspection and copying under the Act. Effective immediately.
Title
DRUG TAKE-BACK ACT
Sponsors
Roll Calls
2022-04-07 - House - Concurrence in House (Y: 95 N: 14 NV: 5 Abs: 0) [PASS]
2022-04-07 - House - Concurrence in House (Y: 95 N: 14 NV: 5 Abs: 0) [PASS]
2022-04-07 - House - Concurrence in House (Y: 95 N: 14 NV: 5 Abs: 0) [PASS]
2022-03-31 - Senate - Third Reading in Senate (Y: 46 N: 2 NV: 11 Abs: 0) [PASS]
2022-02-23 - House - Third Reading in House (Y: 96 N: 13 NV: 4 Abs: 3) [PASS]
2022-04-07 - House - Concurrence in House (Y: 95 N: 14 NV: 5 Abs: 0) [PASS]
2022-04-07 - House - Concurrence in House (Y: 95 N: 14 NV: 5 Abs: 0) [PASS]
2022-03-31 - Senate - Third Reading in Senate (Y: 46 N: 2 NV: 11 Abs: 0) [PASS]
2022-02-23 - House - Third Reading in House (Y: 96 N: 13 NV: 4 Abs: 3) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2022-06-10 | House | Public Act . . . . . . . . . 102-1055 |
| 2022-06-10 | House | Effective Date June 10, 2022 |
| 2022-06-10 | House | Governor Approved |
| 2022-05-12 | House | Sent to the Governor |
| 2022-04-22 | Senate | Added as Alternate Co-Sponsor Sen. Jacqueline Y. Collins |
| 2022-04-13 | House | Passed Both Houses |
| 2022-04-13 | House | Motion to Reconsider Vote - Withdrawn Rep. Daniel Didech |
| 2022-04-07 | House | Motion Filed to Reconsider Vote Rep. Daniel Didech |
| 2022-04-07 | House | House Concurs |
| 2022-04-07 | House | Senate Floor Amendment No. 3 House Concurs 095-014-000 |
| 2022-04-07 | House | Senate Committee Amendment No. 2 House Concurs 095-014-000 |
| 2022-04-07 | House | Senate Committee Amendment No. 1 House Concurs 095-014-000 |
| 2022-04-06 | House | Senate Floor Amendment No. 3 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000 |
| 2022-04-06 | House | Senate Committee Amendment No. 2 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000 |
| 2022-04-06 | House | Senate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000 |
| 2022-04-01 | House | Senate Floor Amendment No. 3 Motion to Concur Referred to Rules Committee |
| 2022-04-01 | House | Senate Committee Amendment No. 2 Motion to Concur Referred to Rules Committee |
| 2022-04-01 | House | Senate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee |
| 2022-04-01 | House | Senate Floor Amendment No. 3 Motion Filed Concur Rep. Jennifer Gong-Gershowitz |
| 2022-04-01 | House | Senate Committee Amendment No. 2 Motion Filed Concur Rep. Jennifer Gong-Gershowitz |
| 2022-04-01 | House | Senate Committee Amendment No. 1 Motion Filed Concur Rep. Jennifer Gong-Gershowitz |
| 2022-03-31 | House | Placed on Calendar Order of Concurrence Senate Amendment(s) 1, 2, 3 |
| 2022-03-31 | House | Arrived in House |
| 2022-03-31 | Senate | Third Reading - Passed; 046-002-000 |
| 2022-03-31 | Senate | Placed on Calendar Order of 3rd Reading |
| 2022-03-31 | Senate | Senate Floor Amendment No. 3 Adopted; Fine |
| 2022-03-31 | Senate | Recalled to Second Reading |
| 2022-03-31 | Senate | Added as Alternate Co-Sponsor Sen. Laura Ellman |
| 2022-03-31 | Senate | Added as Alternate Chief Co-Sponsor Sen. Patricia Van Pelt |
| 2022-03-31 | Senate | Added as Alternate Chief Co-Sponsor Sen. Sara Feigenholtz |
| 2022-03-31 | Senate | Added as Alternate Co-Sponsor Sen. Ann Gillespie |
| 2022-03-30 | Senate | Senate Floor Amendment No. 3 Recommend Do Adopt Executive; 015-000-000 |
| 2022-03-28 | Senate | Senate Floor Amendment No. 3 Assignments Refers to Executive |
| 2022-03-25 | Senate | Senate Floor Amendment No. 3 Referred to Assignments |
| 2022-03-25 | Senate | Senate Floor Amendment No. 3 Filed with Secretary by Sen. Laura Fine |
| 2022-03-23 | Senate | Placed on Calendar Order of 3rd Reading March 24, 2022 |
| 2022-03-23 | Senate | Second Reading |
| 2022-03-23 | Senate | Placed on Calendar Order of 2nd Reading |
| 2022-03-23 | Senate | Do Pass as Amended Executive; 016-000-000 |
| 2022-03-23 | Senate | Senate Committee Amendment No. 2 Adopted |
| 2022-03-23 | Senate | Senate Committee Amendment No. 1 Adopted |
| 2022-03-22 | Senate | Senate Committee Amendment No. 2 Assignments Refers to Executive |
| 2022-03-22 | Senate | Senate Committee Amendment No. 1 Assignments Refers to Executive |
| 2022-03-18 | Senate | Senate Committee Amendment No. 2 Referred to Assignments |
| 2022-03-18 | Senate | Senate Committee Amendment No. 2 Filed with Secretary by Sen. Laura Fine |
| 2022-03-16 | Senate | Senate Committee Amendment No. 1 Referred to Assignments |
| 2022-03-16 | Senate | Senate Committee Amendment No. 1 Filed with Secretary by Sen. Laura Fine |
| 2022-03-02 | Senate | Assigned to Executive |
| 2022-02-23 | Senate | Referred to Assignments |
| 2022-02-23 | Senate | First Reading |
| 2022-02-23 | Senate | Added as Alternate Chief Co-Sponsor Sen. Antonio Muñoz |
| 2022-02-23 | Senate | Chief Senate Sponsor Sen. Laura Fine |
| 2022-02-23 | Senate | Placed on Calendar Order of First Reading |
| 2022-02-23 | Senate | Arrive in Senate |
| 2022-02-23 | House | Third Reading - Short Debate - Passed 096-013-000 |
| 2022-02-22 | House | Placed on Calendar Order of 3rd Reading - Short Debate |
| 2022-02-22 | House | House Floor Amendment No. 2 Adopted |
| 2022-02-22 | House | Second Reading - Short Debate |
| 2022-02-17 | House | House Floor Amendment No. 2 Recommends Be Adopted Rules Committee; 004-000-000 |
| 2022-02-16 | House | House Floor Amendment No. 2 Referred to Rules Committee |
| 2022-02-16 | House | House Floor Amendment No. 2 Filed with Clerk by Rep. Jennifer Gong-Gershowitz |
| 2022-02-15 | House | Added Co-Sponsor Rep. Jaime M. Andrade, Jr. |
| 2022-02-15 | House | Placed on Calendar 2nd Reading - Short Debate |
| 2022-02-10 | House | Added Co-Sponsor Rep. Mark Luft |
| 2022-02-10 | House | Added Co-Sponsor Rep. Joyce Mason |
| 2022-02-09 | House | Added Co-Sponsor Rep. Martin McLaughlin |
| 2022-02-09 | House | Do Pass as Amended / Short Debate Prescription Drug Affordability & Accessibility Committee; 015-002-000 |
| 2022-02-09 | House | House Committee Amendment No. 1 Adopted in Prescription Drug Affordability & Accessibility Committee; by Voice Vote |
| 2022-02-08 | House | House Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee |
| 2022-02-07 | House | Added Co-Sponsor Rep. Anthony DeLuca |
| 2022-02-07 | House | Added Co-Sponsor Rep. Lawrence Walsh, Jr. |
| 2022-02-03 | House | Added Co-Sponsor Rep. Ann M. Williams |
| 2022-02-02 | House | Added Co-Sponsor Rep. Robyn Gabel |
| 2022-02-01 | House | Added Co-Sponsor Rep. Ryan Spain |
| 2022-01-31 | House | House Committee Amendment No. 1 Referred to Rules Committee |
| 2022-01-31 | House | House Committee Amendment No. 1 Filed with Clerk by Rep. Jennifer Gong-Gershowitz |
| 2022-01-27 | House | Added Co-Sponsor Rep. Robert Rita |
| 2022-01-26 | House | Added Chief Co-Sponsor Rep. Tom Demmer |
| 2022-01-11 | House | Assigned to Prescription Drug Affordability & Accessibility Committee |
| 2021-03-27 | House | Rule 19(a) / Re-referred to Rules Committee |
| 2021-03-26 | House | Added Co-Sponsor Rep. Michelle Mussman |
| 2021-03-26 | House | Added Chief Co-Sponsor Rep. Dagmara Avelar |
| 2021-03-11 | House | Added Co-Sponsor Rep. Kambium Buckner |
| 2021-03-09 | House | Assigned to Prescription Drug Affordability & Accessibility Committee |
| 2021-03-09 | House | Added Co-Sponsor Rep. Deb Conroy |
| 2021-03-01 | House | Added Co-Sponsor Rep. Kelly M. Cassidy |
| 2021-02-26 | House | Added Co-Sponsor Rep. Anne Stava-Murray |
| 2021-02-24 | House | Added Co-Sponsor Rep. Terra Costa Howard |
| 2021-02-17 | House | Referred to Rules Committee |
| 2021-02-17 | House | First Reading |
| 2021-02-16 | House | Filed with the Clerk by Rep. Jennifer Gong-Gershowitz |
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| 5 | 140 | 7 | Amended Code | Citation Text |
